After Chinese CDMO fails, Cambrex acquires ingredient manufacturer Snapdragon Chemistry

While CDMO Cambrex has been expanding steadily throughout the year, its latest acquisition sees a deeper dive into the active pharmaceutical ingredient game.

The New Jersey-based CDMO has agreed to acquire Snapdragon Chemistry, a producer of chemical services and API manufacturing for biopharma customers. The deal…
Click here to view original post